Absci Corp. ( (ABSI) ) has released its Q3 earnings. Here is a breakdown of the information Absci Corp. presented to its investors. Absci ...

Good day and thank you for standing by. Welcome to the Absci Q3 2024 Business Update Conference Call. At this time, all ...

Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on AbSci (ABSI – Research Report), retaining the price target of $7.00. Swayampakula Ramakanth’s rating is based on several ...

Good day, and thank you for standing by. Welcome to the Absci Q3 2024 business update conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now ...

On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...

USA News Group News Commentary – A recent World Economic Forum report highlights AI's potential to ease the strain on healthcare systems worldwide, noting Mayo Clinic’s ...

and NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today reported financial and operating results for the quarter ended ...

The Company will host a conference call and live webcast on Tuesday, November 12 at 11:00 a.m. (Eastern Time) to discuss its third quarter 2024 financial results. FreightCar America invites ...

Successfully delivered AI de novo designed antibody sequences to AstraZeneca, fulfilling first milestone under collaboration Entered into collaboration with Twist Bioscience to design a novel antibody ...

Guggenheim has recently initiated Absci Corp (ABSI) stock to Buy rating, as announced on October 2, 2024, according to Finviz. Earlier, on July 3, 2024, Morgan Stanley had initiated the stock to ...

Here are four AI-oriented stocks in the biotech sector. With a market capitalization of around $452 million, Absci ...